SEATTLE — NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed follow-on public offering of $55 million of its common stock. In addition, the Company expects to grant the […]
SAN DIEGO — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced preliminary highlights of the Company’s 2013 performance, accomplishments and outlined key corporate objectives for 2014. Preliminary 2013 Performance Results (unaudited) • Total revenue of approximately $162 million, showing growth of approximately 81% year-over-year for 2013 […]
SANTA CLARA, Calif. — ProteinSimple today introduced Wes, another revolutionary re-invention of the Western blot. Wes is the bold evolution of the popular Simple Western family of instruments, delivering simplicity and performance like no product before it. With just 30 minutes of sample prep, Wes will analyze up to 25 samples in under 3 hours […]
SOUTH SAN FRANCISCO, Calif. – Nature Publishing Group has selected single-cell sequencing as its Method of the Year for 2013 (www.nature.com/nmeth/index.html). The publication, in explaining its choice, noted that “methods to sequence the DNA and RNA of single cells are poised to transform many areas of biology and medicine.” The publication continued: “Single-cell genome and […]
SOUTH SAN FRANCISCO, Calif. –– Fluidigm Corporation (NASDAQ:FLDM) today announced a universal sample prep workflow for single-cell DNA sequencing that runs on its C1™ Single-Cell Auto Prep System. This workflow streamlines targeted, whole exome and whole genome sequencing in heterogeneous cell populations and enables researchers to discover and screen somatic mutations, such as SNP, small […]
STRASBOURG AND MONTRÉAL – Domain Therapeutics, a France-based biopharmaceutical company that specializes in the research and development of new drug candidates that target G-protein coupled receptors (GPCRs), is pleased to announce the signing of a licensing and partnership agreement on GPCR biosensor technology with Université de Montréal (UdeM) and its commercialization unit, with the Institute […]
SANTA CLARA, Calif., and SINGAPORE — Agilent Technologies Inc. (NYSE: A) and Nanyang Technological University today announced they are collaborating on the development of new solutions for the biological treatment of wastewater. In this collaboration, the Nanyang Environment and Water Research Institute (NEWRI), which leads NTU’s efforts in water research, will use Agilent’s bio-analytical instruments […]
Hercules, CA —— Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that Robert M. Malchione has been appointed to its Board of Directors effective January 1, 2014. Mr. Malchione will stand for election to the Board along with Bio-Rad’s other directors […]
CAMBRIDGE, England–Sphere Fluidics Limited has developed unique technology for single cell analysis and characterization and provides proprietary products and novel services for this rapidly-growing market. This enabling approach can find rare variants in large cell populations and Sphere Fluidics has patented novel Cyto-Mine™ technology that permits up to one billion assays per biochip per day. […]
Jena, Germany — Analytik Jena AG has appointed Dr. Marco Tilgner as the new managing director of the Japanese subsidiary AJ Japan as of January 1, 2014. Mr. Tilgner, who will report in his future role to Analytik Jena Chief Executive Officer Klaus Berka, already took over responsibility for finance and administration at the subsidiary […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
